In general practitioners’ research practicesPLUS As part of the FoPraNet-BW project, all study participants have now been enrolled in the INDUCT study, bringing the recruitment phase to a close. The target group for this randomised controlled intervention study comprises adults with obesity (BMI 30–45 kg/m2). Randomisation – that is, the allocation of study participants to the intervention or control group – was carried out using a randomised procedure. Whilst participants in the intervention group practise intermittent fasting for half a year (food intake over an 8-hour period followed by 16 hours without food), participants in the control group undergo the standard treatment for obesity („Treatment as usual“). A follow-up visit is scheduled six months after the end of the intervention phase in both study arms.
The aim of the study is to investigate the effectiveness of 16:8 intermittent fasting amongst patients seen by GPs and „Lessons learnt“to be used as a basis for follow-up studies on obesity in general practitioners’ surgeries in Germany.”.
We would like to thank all the research practicesPLUS and to all participants in the INDUCT study for their support.
Your FoPraNet-BW team